PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
16-Oct-2023 Gilead Demonstrates the Impact of Global Collaboration in Advancing HIV Research and Health Equity at EACS 2023 Businesswire
16-Oct-2023 Innate Pharma Announces Abstracts Selected for ESMO Congress 2023 Businesswire
16-Oct-2023 MUST Connect 2023 Singapore highlighted the cutting-edge innovations of Korean life science startups Businesswire
15-Oct-2023 GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward Businesswire
14-Oct-2023 Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Businesswire
14-Oct-2023 Ankyra Therapeutics Presents Preliminary Phase 1 Canine Clinical Data Evaluating cANK-101 to Treat Advanced Malignant Melanoma in Dogs Businesswire
14-Oct-2023 Verastem Oncology Announces Initial Results of RAMP 203 Trial of Avutometinib and LUMAKRAS™ (sotorasib) in KRAS G12C-Mutant Non-Small Cell Lung Cancer Businesswire
14-Oct-2023 Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting Businesswire
14-Oct-2023 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma1 Businesswire
14-Oct-2023 INFINITY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Businesswire
13-Oct-2023 Shaperon Inc. Makes a Splash at BioFuture™ 2023 With the Announcement of US Subsidiary Hudson Therapeutics Inc. and Positive Clinical Data Businesswire
13-Oct-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors Businesswire
13-Oct-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of John Wiley & Sons, Inc. (WLY) on Behalf of Investors Businesswire
13-Oct-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Lincoln National Corporation (LNC) on Behalf of Investors Businesswire
13-Oct-2023 BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) in Relapsed or Refractory Follicular Lymphoma Businesswire
13-Oct-2023 BIOQuébec and BioFlorida Announce Strategic Partnership Businesswire
13-Oct-2023 Medisca Takes Additional Steps to Protect Its Innovative Technologies Businesswire
13-Oct-2023 BioFuture™ 2023 Wraps Up After Convening Hundreds of High-Profile Attendees and Record Numbers of Investors and Media Businesswire
13-Oct-2023 Late-Breaking Data for Genentech’s BTK Inhibitor Fenebrutinib Show Brain Penetration and Significant Reduction in Lesions in Patients With Relapsing Multiple Sclerosis Businesswire
13-Oct-2023 UAE Calls for Global Consensus on AI Governance Businesswire